Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• PCV13 vaccination highly effective but complicated by serotype replacement
• DAA therapy regardless of SVR reduces hepatic, extrahepatic mortality
• Flu vaccine 47% effective in US, early estimates show
• Hand-to-genital contact unlikely to cause HPV transmission
• ‘Intersecting epidemics’: Drug use doubles in women, straight men with syphilis
• Measles cases in Europe tripled in 2018, WHO says
• Only 16% of teens complete HPV vaccine series by age 13 years
• Pet hedgehogs cause multistate outbreak of Salmonella
• Q&A: Vaccine controversies in the US
• Tafenoquine prevents P. vivax relapse; further study needed
• Trump announces 10-year plan to end HIV epidemic in US
• Acute flaccid myelitis: A mystery disease Donald Kaye, MD, MACP
• FDA to review Merck agents against cUTIs, cIAIs, nosocomial pneumonia
• Phages: A promising alternative in the age of antibiotic resistance?
• Hooked on ID with Dharushana Muthulingam, MD Dharushana Muthulingam, MD
• Among injection drug users, HIV more prevalent in women than men
• Early follow-up associated with lower risk for readmission in OPAT patients
• ‘Friendly competition’ between hospitals improves hand hygiene
• Hand hygiene compliance ‘remarkably low’ among EMS providers
• HIV, syphilis coinfection increases risk for ocular syphilis
• Increase in organ donations likely a result of opioid epidemic; nearly all donations being tested
• Less restrictive OPAT criteria for infective endocarditis safe, effective
• Marijuana use increases risk for lung disease in patients with HIV
• Nonhuman primates are only intermediate hosts for Ebola viruses
• Oral HIV self-testing kit demonstrates 100% specificity, 99.5% sensitivity
• S. stercoralis infection ‘widely prevalent’ in Bolivia
• Shigella shows high resistance to azithromycin, ciprofloxacin
• Social intervention in Brazil increases rate of TB cure by 7.6%
• UV devices decontaminate CT tables
• Montezuma’s revenge: A new treatment option Jeff Brock, PharmD, MBA, BCIDP
• Would it be more beneficial to promote a pneumococcal vaccine that includes all or most serotypes to prevent disease or a ‘custom’ vaccine based on serotype prevalence?